Table 2.
Prevalence of individual comorbid conditions in participants with T2D
| Diseases | No n (%) | Yes n (%) |
| Hypertension | 509 (49.6) | 527 (50.4) |
| Obesity | 738 (71.3) | 298 (28.7) |
| Hyperlipidaemia | 910 (87.8) | 126 (12.2) |
| Coronary artery disease | 825 (79.6) | 211 (20.4) |
| Cerebrovascular disease | 991 (95.6) | 45 (4.4) |
| Cardiovascular disease | 890 (85.9) | 146 (14.1) |
| Kidney disease | 892 (86.1) | 144 (13.9) |
| Asthma/COPD (chronic obstructive pulmonary disease) | 942 (90.9) | 94 (9.1) |
| Neuropathy | 776 (74.9) | 260 (25.1) |
| Retinopathy | 522 (50.4) | 514 (49.6) |
| Nephropathy | 939 (90.6) | 97 (9.4) |
| Diabetic foot | 839 (81.0) | 197 (19.0) |
| Oral problem | 765 (73.8) | 271 (26.2) |
| Number of chronic diseases | ||
| <2 | 607 (58.6) | |
| 2–3 | 388 (37.4) | |
| ≥4 | 41 (4.0) | |
| Comorbidities (having two or more physical conditions) | 607 (58.6) | 429 (41.4) |
COPD, chronic obstructive pulmonary disease; T2D, type-2 diabetes.